NCT03302806View on ClinicalTrials.gov

Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis

CompletedOBSERVATIONAL

Enrollment

103

Participants

Timeline

Start Date

June 29, 2016

Primary Completion Date

October 4, 2017

Study Completion Date

October 24, 2018

Conditions

Progressive Multiple Sclerosis

Interventions

OTHER

Non interventional Study

Trial Locations (1)

44093

Nantes University Hospital, Nantes

All Listed Sponsors

lead

Nantes University Hospital

OTHER

NCT03302806 - Study to Assess Effect and Safety of High Dose of Biotin (Qizenday®) in Progressive Multiple Sclerosis | Biotech Hunter | Biotech Hunter